Type II hereditary angioneurotic edema that may result from a single nucleotide change in the codon for alanine-436 in the C1 inhibitor gene.
- 1 January 1990
- journal article
- research article
- Published by Proceedings of the National Academy of Sciences in Proceedings of the National Academy of Sciences
- Vol. 87 (1) , 265-268
- https://doi.org/10.1073/pnas.87.1.265
Abstract
Identical single-base changes in the C1 inhibitor gene that may result in dysfunctional inhibitor proteins are described in two different families with type II hereditary angioneurotic edema. Initially, a restriction fragment length polymorphism was defined that resulted from loss of a Pst I site within exon VIII, which encodes the region containing the reactive center. Exon VIII from the normal and abnormal allelles was amplified by the polymerase chain reaction. Amplified DNA product was cloned into plasmid pUC18; clones representing normal and mutant allelles were distinguished by the presence and absence, respectively, of the Pst I restriction site. DNA sequence analysis revealed a G----A mutation in the codon for alanine-436, which would result in replacement with a threonine residue. This position is nine amino acid residues amino-terminal to the reactive-center arginylthreonine peptide bond. In contrast, previously defined mutations in type II hereditary angioneurotic edema result in replacement of the reactive-center arginine.This publication has 36 references indexed in Scilit:
- Plasma serine proteinase inhibitors (serpins) exhibit major conformational changes and a large increase in conformational stability upon cleavage at their reactive sites.Journal of Biological Chemistry, 1988
- Heat- and alkali-induced deamination of 5-methylcytosine and cytosine residues in DNABiochimica et Biophysica Acta (BBA) - Gene Structure and Expression, 1982
- Efficient transfer of large DNA fragments from agarose gels to diazobenzyloxymethyl-paper and rapid hybridization by using dextran sulfate.Proceedings of the National Academy of Sciences, 1979
- Response of Variant Hereditary Angioedema Phenotypes to Danazol TherapyJournal of Clinical Investigation, 1979
- Molecular basis of base substitution hotspots in Escherichia coliNature, 1978
- DNA sequencing with chain-terminating inhibitorsProceedings of the National Academy of Sciences, 1977
- Studies on human plasma C1 inactivator-enzyme interactions. I. Mechanisms of interaction with C1s, plasmin, and trypsin.Journal of Clinical Investigation, 1975
- Genetically determined heterogeneity of the C1 esterase inhibitor in patients with hereditary angioneurotic edemaJournal of Clinical Investigation, 1971
- Inhibition of activated Hageman factor and activated plasma thromboplastin antecedent by purified serum C1 inactivator.1970
- Interaction of Plasma Kallikrein with the C1̄ InhibitorThe Journal of Immunology, 1970